SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-273579
Filing Date
2023-11-08
Accepted
2023-11-08 16:41:52
Documents
13
Period of Report
2023-11-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d454419d8k.htm   iXBRL 8-K 21415
5 GRAPHIC g454419g1106225433228.jpg GRAPHIC 2307
  Complete submission text file 0001193125-23-273579.txt   145471

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA biib-20231106.xsd EX-101.SCH 2859
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE biib-20231106_lab.xml EX-101.LAB 17235
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE biib-20231106_pre.xml EX-101.PRE 10818
7 EXTRACTED XBRL INSTANCE DOCUMENT d454419d8k_htm.xml XML 3204
Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Filer) CIK: 0000875045 (see all company filings)

IRS No.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19311 | Film No.: 231388616
SIC: 2836 Biological Products, (No Diagnostic Substances)